DE60336736D1 - Codon-optimierte synthetische plasmide - Google Patents
Codon-optimierte synthetische plasmideInfo
- Publication number
- DE60336736D1 DE60336736D1 DE60336736T DE60336736T DE60336736D1 DE 60336736 D1 DE60336736 D1 DE 60336736D1 DE 60336736 T DE60336736 T DE 60336736T DE 60336736 T DE60336736 T DE 60336736T DE 60336736 D1 DE60336736 D1 DE 60336736D1
- Authority
- DE
- Germany
- Prior art keywords
- plasmide
- codon
- optimized synthetic
- optimized
- synthetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39624702P | 2002-07-16 | 2002-07-16 | |
PCT/US2003/021917 WO2004007678A2 (en) | 2002-07-16 | 2003-07-15 | Codon optimized synthetic plasmids |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60336736D1 true DE60336736D1 (de) | 2011-05-26 |
Family
ID=30115994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60336736T Expired - Lifetime DE60336736D1 (de) | 2002-07-16 | 2003-07-15 | Codon-optimierte synthetische plasmide |
Country Status (8)
Country | Link |
---|---|
US (2) | US7316925B2 (de) |
EP (1) | EP1543020B1 (de) |
AR (1) | AR040575A1 (de) |
AT (1) | ATE505476T1 (de) |
AU (1) | AU2003249208B2 (de) |
DE (1) | DE60336736D1 (de) |
TW (1) | TW200403338A (de) |
WO (1) | WO2004007678A2 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE457029T1 (de) | 2001-06-05 | 2010-02-15 | Curevac Gmbh | Stabilisierte mrna mit erhöhtem g/c-gehalt, enkodierend für ein bakterielles antigen sowie deren verwendung |
DE10162480A1 (de) | 2001-12-19 | 2003-08-07 | Ingmar Hoerr | Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen |
BR0314619A (pt) * | 2002-09-18 | 2005-08-02 | Univ Montreal Ct Hospitalier Chum | Análogos de ghrh |
US7361642B2 (en) | 2003-08-04 | 2008-04-22 | Vgx Pharmaceuticals, Inc. | Canine specific growth hormone releasing hormone |
EP1761558A1 (de) * | 2004-06-30 | 2007-03-14 | Allergan, Inc. | Verbesserung der expression von activen botulinum toxin type e |
MX2007001292A (es) * | 2004-08-03 | 2007-07-04 | Geneart Ag | Metodo para modular la expresion genica al alterar el contendido de cpg. |
AU2005271372B2 (en) * | 2004-08-04 | 2012-05-03 | Allergan, Inc. | Optimizing expression of active botulinum toxin type A |
DE102004042546A1 (de) * | 2004-09-02 | 2006-03-09 | Curevac Gmbh | Kombinationstherapie zur Immunstimulation |
EP1800289B1 (de) * | 2004-09-09 | 2012-05-23 | QUALCOMM Incorporated | Eindurchgangs-bildverzerrungssystem und -verfahren mit anisotroper filterung |
US7846720B2 (en) * | 2005-01-26 | 2010-12-07 | Vgx Pharmaceuticals, Inc. | Optimized high yield synthetic plasmids |
WO2009022236A2 (en) | 2007-08-16 | 2009-02-19 | Tripep Ab | Immunogen platform |
CN201397956Y (zh) * | 2009-03-23 | 2010-02-03 | 富士康(昆山)电脑接插件有限公司 | 电连接器组件 |
AU2010279294B2 (en) * | 2009-08-06 | 2014-12-04 | Cmc Icos Biologics, Inc. | Methods for improving recombinant protein expression |
EP3578205A1 (de) | 2010-08-06 | 2019-12-11 | ModernaTX, Inc. | Pharmazeutische zusammensetzungen enthaltenbearbeitete nukleinsäuren und ihre medizinische verwendung |
CA2813466A1 (en) | 2010-10-01 | 2012-04-05 | Moderna Therapeutics, Inc. | Modified nucleosides, nucleotides, and nucleic acids that disrupt major groove binding partner interactions |
EP2691101A2 (de) | 2011-03-31 | 2014-02-05 | Moderna Therapeutics, Inc. | Freisetzung und formulierung von manipulierten nukleinsäuren |
US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
KR102014061B1 (ko) | 2011-10-03 | 2019-08-28 | 모더나 세라퓨틱스, 인코포레이티드 | 변형된 뉴클레오사이드, 뉴클레오타이드, 및 핵산, 및 이들의 용도 |
US8993316B2 (en) | 2011-11-16 | 2015-03-31 | Brian P. Hanley | Methods and compositions for gene therapy and GHRH therapy |
LT2791160T (lt) | 2011-12-16 | 2022-06-10 | Modernatx, Inc. | Modifikuotos mrnr sudėtys |
WO2013119371A2 (en) * | 2012-02-10 | 2013-08-15 | The Board Of Trustees Of The Leland Stanford Junior University | Mini-intronic plasmid vectors |
US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
US9254311B2 (en) | 2012-04-02 | 2016-02-09 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
AU2013243947A1 (en) | 2012-04-02 | 2014-10-30 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
CA2892529C (en) | 2012-11-26 | 2023-04-25 | Moderna Therapeutics, Inc. | Terminally modified rna |
US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
MX2016004249A (es) | 2013-10-03 | 2016-11-08 | Moderna Therapeutics Inc | Polinulcleotidos que codifican el receptor de lipoproteina de baja densidad. |
WO2015062738A1 (en) | 2013-11-01 | 2015-05-07 | Curevac Gmbh | Modified rna with decreased immunostimulatory properties |
EP3134131B1 (de) | 2014-04-23 | 2021-12-22 | ModernaTX, Inc. | Nukleinsäureimpfstoffe |
WO2020014528A1 (en) * | 2018-07-13 | 2020-01-16 | The Regents Of The University Of California | Retrotransposon-based delivery vehicle and methods of use thereof |
US11795207B2 (en) | 2021-03-30 | 2023-10-24 | AAVnerGene Inc. | Modified plasma clotting factor VIII and method of use thereof |
JP2024511851A (ja) | 2021-03-30 | 2024-03-15 | エーエーブイネルジーン インク. | 改変血漿凝固第viii因子およびその使用方法 |
US20230365991A1 (en) | 2022-05-12 | 2023-11-16 | AAVnerGene Inc. | Compositions and methods for recombinant parvovirus production |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5134120A (en) * | 1984-08-03 | 1992-07-28 | Cornell Research Foundation, Inc. | Use of growth hormone to enhance porcine weight gain |
FR2622455B1 (fr) * | 1987-11-04 | 1991-07-12 | Agronomique Inst Nat Rech | Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes |
US5298422A (en) * | 1991-11-06 | 1994-03-29 | Baylor College Of Medicine | Myogenic vector systems |
JP2586367B2 (ja) * | 1992-04-15 | 1997-02-26 | 日本電気株式会社 | 軟磁性材料とその製造方法および磁気ヘッド |
US6114148C1 (en) * | 1996-09-20 | 2012-05-01 | Gen Hospital Corp | High level expression of proteins |
AU8589998A (en) * | 1997-07-24 | 1999-02-16 | Valentis, Inc. | Ghrh expression system and methods of use |
US6924365B1 (en) * | 1998-09-29 | 2005-08-02 | Transkaryotic Therapies, Inc. | Optimized messenger RNA |
US6551996B1 (en) * | 1999-07-26 | 2003-04-22 | Baylor College Of Medicine | Super-active porcine growth hormone releasing hormone analog |
BR0108962A (pt) * | 2000-03-03 | 2002-12-24 | Valentis Inc | Formulações de ácido nucléico para distribuição de genes e métodos de uso |
AR035671A1 (es) * | 2000-12-12 | 2004-06-23 | Advisys Inc | Administracion de secuencia de acido nucleico a un animal hembra, para aumentar el crecimiento de la descendencia |
-
2003
- 2003-07-15 DE DE60336736T patent/DE60336736D1/de not_active Expired - Lifetime
- 2003-07-15 EP EP03764596A patent/EP1543020B1/de not_active Expired - Lifetime
- 2003-07-15 US US10/619,939 patent/US7316925B2/en active Active
- 2003-07-15 AT AT03764596T patent/ATE505476T1/de not_active IP Right Cessation
- 2003-07-15 AR AR20030102543A patent/AR040575A1/es unknown
- 2003-07-15 TW TW092119326A patent/TW200403338A/zh unknown
- 2003-07-15 WO PCT/US2003/021917 patent/WO2004007678A2/en not_active Application Discontinuation
- 2003-07-15 AU AU2003249208A patent/AU2003249208B2/en not_active Expired
-
2007
- 2007-11-16 US US11/941,876 patent/US20080194511A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040092009A1 (en) | 2004-05-13 |
US7316925B2 (en) | 2008-01-08 |
WO2004007678A3 (en) | 2004-08-12 |
EP1543020A2 (de) | 2005-06-22 |
ATE505476T1 (de) | 2011-04-15 |
EP1543020A4 (de) | 2006-11-22 |
US20080194511A1 (en) | 2008-08-14 |
WO2004007678A2 (en) | 2004-01-22 |
AR040575A1 (es) | 2005-04-13 |
EP1543020B1 (de) | 2011-04-13 |
WO2004007678B1 (en) | 2004-10-07 |
AU2003249208A1 (en) | 2004-02-02 |
AU2003249208B2 (en) | 2010-03-04 |
TW200403338A (en) | 2004-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60336736D1 (de) | Codon-optimierte synthetische plasmide | |
ATE419765T1 (de) | Borste | |
DE60325448D1 (de) | ste | |
SE0402743L (sv) | Förbättrade belagda slipmedel | |
IS7471A (is) | Ný efnasambönd | |
IS7879A (is) | Ný efnasambönd | |
BR0313322B1 (pt) | escova de dentes | |
IS7827A (is) | Ný efnasambönd | |
DE60311524D1 (de) | Zahnbürste | |
DE60302398D1 (de) | Poliervorrichtung | |
DE60234477D1 (de) | Druckspeicher-flüssigkeitssprühvorrichtung | |
DK1492934T3 (da) | Dørenhed | |
DE60319512D1 (de) | Drehgelenk | |
AU152559S (en) | Brush | |
NO20032637D0 (no) | Tannbörste | |
DE60309627D1 (de) | Haarbürste | |
ES1051991Y (es) | Cepillo | |
ITMI20021327A1 (it) | Nuove ossialchilpiperazine | |
SE0103448D0 (sv) | Buskröjare | |
NO20023574D0 (no) | Tannbörste | |
SE0200708D0 (sv) | Tandborste | |
SE0101394D0 (sv) | Borstanordning | |
FIU20020148U0 (fi) | Ruokailuryhmä-Varavuode | |
UA7989S (uk) | Шнур | |
SE0202963D0 (sv) | New use |